1-5 of 5
Deepa Kolaseri Krishnadas
Close
Sort by
Journal Articles

Phase I Study of FT538 + Daratumumab for Treatment of r/r AML

Joseph E. Maakaron, Cassie Seichter, Rose Wangen, Andrea Hoeschen, Deepa Kolaseri Krishnadas, Kateryna Kent, Ryan Shanley, Daniel O'Leary, Najla H El Jurdi, Shernan G. Holtan, Brian Betts, Mark Juckett, Jeffrey S Miller
Journal: Blood
Blood (2023) 142 (Supplement 1): 4842.
https://doi.org/10.1182/blood-2023-189132
Published: 2023
Journal Articles

CT Antigen-Specific Immune Response From DAC/DC Vaccine Correlates With Clinical Outcome In Patients With Relapsed Neuroblastoma

Deepa Kolaseri Krishnadas, PhD, Fanqi Bai, MD, Kenneth Lucas
Journal: Blood
Blood (2013) 122 (21): 2023.
https://doi.org/10.1182/blood.V122.21.2023.2023
Published: 2013
Journal Articles

In Vitro Stimulation with WT1-Peptide Mix Elicits Functional Polyclonal CTL From Adult Donors and Cord Blood

Deepa Kolaseri Krishnadas, PhD, Mindy Stamer, MS, Kim Dunham, BS, Lei Bao, PhD, Kenneth Lucas, MD
Journal: Blood
Blood (2010) 116 (21): 2096.
https://doi.org/10.1182/blood.V116.21.2096.2096
Published: 2010
Journal Articles

HLA-A*0201 Restricted Killing Activity of WT1-Specific CTL Generated From the Peripheral Blood Lymphocytes of Normal Healthy Donors.

Deepa Kolaseri Krishnadas, PhD, Mindy Stamer, BS, Kim Dunham, BS, Lei Bao, PhD, Kenneth Lucas, MD
Journal: Blood
Blood (2009) 114 (22): 3026.
https://doi.org/10.1182/blood.V114.22.3026.3026
Published: 2009
Journal Articles

In Vitro Generation of Cytotoxic T Lymphocytes against MAGE A1 and MAGE A3 Derived From Healthy Donors.

Lei Bao, MD, PhD, Mindy M Stamer, BS, Kimberly Dunham, BS, Deepa Kolaseri Krishnadas, PhD, Kenneth G Lucas, MD
Journal: Blood
Blood (2009) 114 (22): 4079.
https://doi.org/10.1182/blood.V114.22.4079.4079
Published: 2009